BROACH.BO · BSE
BROACH LIFECARE HOSPITAL LIMIT
₹15.5
-11.83% (-₹2.08)
Prev. close
₹17.58
Volume
12,000
As of
03 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About BROACH LIFECARE HOSPITAL LIMIT
Broach Lifecare Hospital Limited engages in the business of hospital and healthcare services in India. It provides general medical care, indoor care, intensive care, and critical care and ventilator support facilities, as well as medications and pharmaceutical, day care, electrocardiogram, 2D-echo, treadmill test, Holter monitor, lab treatment, and X-ray services. The company was incorporated in 2023 and is based in Bharuch, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Jaykumar Narendra Vyas
Headquarters
Bharuch
Website
maplehospital.inExchange
View on BSE ↗Key stats
Market cap
₹9.41 Cr
P/E ratio (TTM)
110.7
EPS (TTM)
₹0.14
Beta (1Y · daily vs NIFTY 50)
0.44
Shares float
14.75 L
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹1.82 Cr | ₹2.61 Cr | ₹3.18 Cr | ₹6.00 Cr | |
| EBITDA | — | ₹84.00 L | ₹1.03 Cr | ₹87.35 L | ₹55.00 L |
| — | ₹13.85 L | ₹69.76 L | ₹53.60 L | ₹8.70 L | |
| Diluted EPS | ₹0.76 | ₹0.23 | ₹1.15 | ₹0.98 | ₹0.14 |
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹8.18 Cr | ₹5.72 Cr | ₹10.92 Cr | ₹10.76 Cr | |
| ₹5.94 Cr | ₹0 | ₹1.05 Cr | ₹0 | |
| Stockholders' equity | ₹2.16 Cr | ₹5.47 Cr | ₹9.36 Cr | ₹9.45 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹-95.13 L | ₹-3.31 Cr | ₹-62.18 L | ₹1.30 Cr | |
| Investing cash flow | — | ₹-1.78 Cr | ₹-1.39 Cr | ₹-3.64 Cr | ₹-14.08 L |
| — | ₹2.86 Cr | ₹4.77 Cr | ₹4.38 Cr | ₹-1.09 Cr | |
| Capital expenditure | — | ₹-1.88 Cr | ₹-1.39 Cr | ₹-40.08 L | ₹-3.28 Cr |
| End cash position | — | ₹20.01 L | ₹7.34 L | ₹19.63 L | ₹27.13 L |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.41 L Cr | ₹1,868.9 | 36.5 | 5.27 | 13.7% | 0.06 | +11.9% | +12.9% |
| Divi's Laboratories Limited | ₹2.49 L Cr | ₹9,410.5 | 84.7 | 14.85 | 15.3% | 0.00 | +12.3% | +51.8% |
| Torrent Pharmaceuticals Limited | ₹1.84 L Cr | ₹4,970 | 77.5 | 21.95 | 25.8% | 1.79 | +21.5% | +36.9% |
| Apollo Hospitals Enterprise Limited | ₹1.29 L Cr | ₹8,912 | 61.7 | 13.57 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.25 L Cr | ₹683.85 | 188.8 | 14.29 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,161 | 25.8 | 4.27 | 18.6% | 0.46 | +18.4% | +11.9% |
| Cipla Limited | ₹1.13 L Cr | ₹1,386.1 | 33.4 | 3.27 | 11.3% | 0.02 | +2.1% | -12.0% |
| Laurus Labs Limited | ₹1.06 L Cr | ₹2,017.5 | 96.2 | 19.92 | 16.8% | 0.48 | +22.0% | +116.4% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Aurobindo Pharma Limited | ₹99,770.53 Cr | ₹1,713.4 | 27.1 | 2.63 | 9.2% | 0.21 | +6.4% | +53.1% |
| Dr. Reddy's Laboratories Limited | ₹98,709.15 Cr | ₹1,198.3 | 29.8 | 2.62 | 11.4% | 0.21 | +3.2% | -9.3% |
| BROACH LIFECARE HOSPITAL LIMIT | ₹9.41 Cr | ₹15.5 | 110.7 | 1.00 | 0.9% | 0.00 | +88.5% | -25.8% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.